How do I hire a fractional Chief Revenue Officer for a healthtech company in 2027?
Direct Answer
Hiring a fractional CRO for healthtech is a practical alternative to a full-time hire when you need seasoned revenue leadership without the long-term commitment or full compensation package. The key is to match the fractional CRO's specific healthtech experience (regulatory sales cycles, value-based care, HIPAA compliance in GTM messaging) to your company's stage—pre-revenue, early-stage (under $2M ARR), or growth-stage ($2M–$10M ARR). You should expect a rigorous vetting process that includes reference checks with founders at similar-stage healthtech companies, not just general SaaS references. Be honest about your current revenue infrastructure: if you lack basic CRM hygiene or a repeatable sales process, a fractional CRO will spend the first 30–60 days building foundations rather than driving immediate revenue.
Understanding the Healthtech Context in 2027
Healthtech companies face a unique revenue challenge that general SaaS fractional CROs may not fully grasp. Your buyers include hospital systems, physician groups, and payers—organizations with procurement cycles that involve compliance, security reviews, and clinical validation. A fractional CRO who has only sold to SMBs or mid-market tech companies will struggle to navigate these multi-stakeholder sales where a single deal can take 6–12 months. Look for candidates who can describe how they've handled HIPAA business associate agreements, value analysis committees, and regulatory gatekeeping in prior roles. The best healthtech fractional CROs often come from companies like Athenahealth, Epic, or Cerner, or from healthtech startups that scaled past $10M ARR.
Cost Realities and What Drives Them
The monthly cost of a fractional CRO depends on three primary factors: the number of days per week they commit, the stage of your company, and the scope of work. A strategic-only engagement (2 days/week, no direct pipeline management) might run $8,000–$12,000 per month. A full-throttle engagement (4 days/week, including coaching reps, closing key deals, and building processes) can reach $20,000–$25,000 per month. For early-stage healthtech companies (under $2M ARR), expect a higher equity component—often 1.0%–2.0% of fully diluted shares—because the cash risk is higher for the fractional CRO. Growth-stage companies ($2M–$10M ARR) typically pay closer to the top end of the cash range with a smaller equity slice (0.5%–1.0%). Be wary of fractional CROs who quote a flat rate without understanding your current revenue infrastructure; if you lack a clean CRM or a documented sales process, they will need to bill for discovery and setup time.
How to Vet a Fractional CRO for Healthtech
Your vetting process should be more rigorous than a typical SaaS CRO hire. Start by asking for three reference calls with founders or CEOs at healthtech companies where the candidate served as a fractional CRO. Ask those references: "What specific regulatory or compliance hurdle did they help you navigate?" and "How did they adjust your sales process for value-based care or risk-based contracting?" Next, evaluate their operational toolkit. A strong fractional CRO should be fluent in Salesforce or HubSpot, comfortable with Gong for call analysis, and able to use Clari or similar tools for pipeline forecasting. They should also have a clear framework for weekly revenue reviews—not just "let's look at the pipeline," but a structured agenda covering conversion rates, deal stages, and rep activity metrics. Finally, assess their network in healthtech. A well-connected fractional CRO can open doors to channel partners, strategic advisors, or even potential acquirers—this is often worth more than their direct sales output.
The First 90 Days: What to Expect
A properly onboarded fractional CRO should deliver a 30-60-90 day plan within the first week. In the first 30 days, they will audit your CRM data quality, review your current sales process, and interview your team to understand strengths and gaps. They should produce a revenue operations assessment that identifies quick wins (e.g., fixing lead routing, cleaning up pipeline stages) and structural issues (e.g., lack of buyer personas, weak qualification criteria). By day 60, they should have implemented a weekly revenue cadence—a standing meeting with you and the sales team to review pipeline, forecast accuracy, and rep performance. By day 90, you should see measurable changes in pipeline hygiene and at least one or two process improvements that are already in use. If you don't see these milestones, it's a red flag that the fractional CRO may be overcommitted or underprepared for healthtech's complexity.
When a Fractional CRO Is the Wrong Choice
Fractional CROs are not a cure-all. If your healthtech company is pre-revenue with no product-market fit, a fractional CRO cannot fix that—you need a founder-led sales effort or a product-market fit advisor. If your sales team is toxic or deeply underperforming, a part-time leader may not have the authority or time to fire and rebuild. In those cases, a full-time CRO or VP of Sales with a mandate to restructure is more appropriate. Also, if your revenue operations are nonexistent (no CRM, no pipeline tracking, no sales process), a fractional CRO will spend most of their time on basics that a full-time operations hire could handle cheaper. Finally, be honest about your own willingness to be managed. A fractional CRO will push you to make decisions on pricing, hiring, and strategy. If you resist accountability, the engagement will fail regardless of the CRO's skill.
How to Find Candidates
FAQ
What is the typical length of a fractional CRO engagement in healthtech? Most engagements run 6 to 18 months. The first 90 days are critical for assessing fit, and many contracts include a mutual 30-day notice clause after that period. Longer engagements are common if the company is scaling from $2M to $10M ARR.
How many days per week does a fractional CRO typically work? Usually 2 to 4 days per week. Two days is common for strategic oversight; three to four days is needed if the CRO is also coaching reps and managing key deals. Some fractional CROs offer a "burst" model—intensive work for 2–3 weeks per month, then lighter weeks.
Can a fractional CRO help with fundraising or investor relations? Yes, if they have prior experience. Many fractional CROs can prepare revenue projections, build investor-ready pipeline reports, and join investor calls. Make this expectation explicit in the scope of work, as it may increase the monthly rate.
What if I need to terminate the engagement early? Standard contracts include a 30-day notice clause for either party. Some fractional CROs ask for a 60-day notice if they have turned down other clients. Always negotiate this upfront and get it in writing.
How do I know if a fractional CRO is overcommitted? Ask for their current client list and the number of hours they dedicate to each. A fractional CRO managing more than 3–4 clients simultaneously is likely overcommitted and will struggle to give you adequate attention. Request a weekly time allocation estimate.
Should I hire a fractional CRO or a fractional VP of Sales? A fractional CRO is better if you need strategic oversight across marketing, sales, and customer success. A fractional VP of Sales is better if you have a strong marketing and CS team already and just need sales execution. For healthtech companies under $5M ARR, a fractional CRO is usually the right choice because you need cross-functional alignment.
Sources
People also search for: fractional chief revenue officer healthtech company · hire a fractional chief revenue officer for healthtech company · healthtech company fractional chief revenue officer · fractional chief revenue officer near me